These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 17691416)

  • 1. [Coping self-efficacy against alcohol and other drugs use as treatment outcome predictor and its relation with personality dimensions: evaluation of a sample of addicts using DTCQ, VIP and MCM-II].
    Chicharro Romero J; Pedrero Pérez EJ; Pérez López M
    Adicciones; 2007; 19(2):141-51. PubMed ID: 17691416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A brief measure for the assessment of coping self-efficacy among alcohol and other drug users.
    Sklar SM; Turner NE
    Addiction; 1999 May; 94(5):723-9. PubMed ID: 10563037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substance-use situations and abstinence predictions in substance abusers with and without personality disorders.
    Van Horn DH; Frank AF
    Am J Drug Alcohol Abuse; 1998 Aug; 24(3):395-404. PubMed ID: 9741942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of the drug-taking confidence questionnaire: a measure of coping self-efficacy.
    Sklar SM; Annis HM; Turner NE
    Addict Behav; 1997; 22(5):655-70. PubMed ID: 9347068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-cultural adaptation of the drug-taking confidence questionnaire drug version for use in Brazil.
    Cordeiro Vasconcelos S; Botelho Sougey E; da Silva Frazão I; Turner NE; Pinheiro Ramos V; Duarte da Costa Lima M
    BMC Med Res Methodol; 2016 May; 16():55. PubMed ID: 27193075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validity of self-efficacy scale scores for a Spanish sample.
    López-Torrecillas F; García J; Cañadas GA; Uclés IR; De La Fuente EI
    Psychol Rep; 2006 Apr; 98(2):437-50. PubMed ID: 16796100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the World Health Organization Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): report of results from the Australian site.
    Newcombe DA; Humeniuk RE; Ali R
    Drug Alcohol Rev; 2005 May; 24(3):217-26. PubMed ID: 16096125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-efficacy as a predictor of outcome after residential treatment programs for alcohol dependence: simply ask the patient one question!
    Ludwig F; Tadayon-Manssuri E; Strik W; Moggi F
    Alcohol Clin Exp Res; 2013 Apr; 37(4):663-7. PubMed ID: 23075331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of self-efficacy and coping on quality of life and social participation after acquired brain injury: a 1-year follow-up study.
    Brands I; Köhler S; Stapert S; Wade D; van Heugten C
    Arch Phys Med Rehabil; 2014 Dec; 95(12):2327-34. PubMed ID: 24973499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Self-esteem, coping, perceived social support and substance use in young adults with a cannabis dependence disorder].
    Dorard G; Bungener C; Corcos M; Berthoz S
    Encephale; 2014 Jun; 40(3):255-62. PubMed ID: 23928065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting domain-specific insight of schizophrenia patients from symptomatology, multiple neurocognitive functions, and personality related traits.
    Ritsner MS; Blumenkrantz H
    Psychiatry Res; 2007 Jan; 149(1-3):59-69. PubMed ID: 17137634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Broad and specific personality dimensions associated with major depression in a nationally representative sample.
    Cox BJ; McWilliams LA; Enns MW; Clara IP
    Compr Psychiatry; 2004; 45(4):246-53. PubMed ID: 15224266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Failure effects and gender differences in perfectionism].
    Masson AM; Cadot M; Ansseau M
    Encephale; 2003; 29(2):125-35. PubMed ID: 14567164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of Avoidant Personality Disorder on the persistence of Generalized Social Anxiety Disorder in the general population: results from a longitudinal, nationally representative mental health survey.
    Cox BJ; Turnbull DL; Robinson JA; Grant BF; Stein MB
    Depress Anxiety; 2011 Mar; 28(3):250-5. PubMed ID: 21308885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Psychopathological symptoms and personality traits in alcohol-dependent patients: a comparative study].
    Bravo de Medina R; Echeburúa E; Aizpiri J
    Adicciones; 2007; 19(4):373-81. PubMed ID: 18173100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship of behavioural undercontrol to alcoholism in higher-functioning adults.
    Schuckit MA; Smith TL
    Drug Alcohol Rev; 2006 Sep; 25(5):393-402. PubMed ID: 16939933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Personality disorder dimensions of MCMI-II in treated substance addicts].
    Pedrero Pérez EJ
    Adicciones; 2009; 21(1):29-37. PubMed ID: 19333522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Personality disorders in alcoholics: a comparative pilot study between the IPDE and the MCMI-II.
    Fernández-Montalvo J; Landa N; López-Goñi JJ; Lorea I
    Addict Behav; 2006 Aug; 31(8):1442-8. PubMed ID: 16236456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substance use disorders among personality disordered patients admitted for day hospital treatment. Implications for service developments.
    Karterud S; Arefjord N; Andresen NE; Pedersen G
    Nord J Psychiatry; 2009; 63(1):57-63. PubMed ID: 19172500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of substance abusers on the MCMI-III and the Rorschach.
    Vanem PC; Krog D; Hartmann E
    Scand J Psychol; 2008 Feb; 49(1):83-91. PubMed ID: 18190406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.